Skip to main content
Premium Trial:

Request an Annual Quote

IntegenX Gets $5M Loan from Square 1 Bank

Premium

Square 1 Bank said today that it has provided a $5 million debt facility to sample preparation firm IntegenX.

Based in Pleasanton, Calif., privately held IntegenX integrates advanced fluidics and robotic capabilities to produce sample-to-answer products for DNA-based forensics and human identity testing, next-generation sequencing, biodefense, and molecular diagnostics applications.

Last week, IntegenX announced that it had secured $40 million in Series C financing to accelerate the development of its product pipeline and commercialization of its RapidHit 200 Human Identification System in the US and international markets (PCR Insider, 12/15/2011).

IntegenX also markets the Apollo 324, an automated platform for next-generation sequencing DNA and RNA library preparation; and the GenTegra and GenPlate products for stabilizing DNA, RNA, whole blood, and biological fluids for dry-state, room-temperature storage without degradation.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.